The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 112: 1839-1844.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kierszenbaum, F.
Right arrow Articles by Pizzimenti, M. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kierszenbaum, F.
Right arrow Articles by Pizzimenti, M. C.

Phagocytosis: A Defense Mechanism against Infection with Trypanosoma Cruzi1

Felipe Kierszenbaum2, Eva Knecht, Delia B. Budzko2 and María C. Pizzimenti

From the Institute of Microbiology and Parasitology, University of Buenos Aires, School of Medicine, Buenos Aires, Argentina

Abstract

In mice, depression of reticuloendothelial activity by intravenous injection of silica particles resulted in a decreased resistance to infection with virulent blood forms (trypomastigotes) of Trypanosoma cruzi. In these animals, both the mortality rate and the levels of parasitemia were significantly increased over those of control mice given only the parasites. Accordingly, stimulation of the reticuloendothelial system (RES) with diethylstilbestrol (DES) before infection reduced considerably both the mortality rate and the levels of parasitemia, and prolonged the survival time after infection. Although in low percentages (16 to 25%), survival after the 60-day observation period was observed only among mice which had been treated with DES.

Virulent trypomastigote forms of T. cruzi were found inside mouse peritoneal macrophages shortly after intraperitoneal (i.p.) injection. Many of the parasites were killed within these cells both in vivo and in vitro.

The data reported in this paper indicate that, in the mouse, the RES is involved in the resistance against infection with virulent blood forms of T. cruzi, possibly through the capacity of macrophages to destroy the parasite.

Footnotes

1 These studies were supported by United States Public Health Service Grant AI-09702 from the National Institute of Allergy and Infectious Diseases and by the Consejo Nacional de Investigaciones Cientificas y Técnicas of Argentina (CONICET).

2 Career Investigator of the CONICET.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
F. Kierszenbaum
Chagas' Disease and the Autoimmunity Hypothesis
Clin. Microbiol. Rev., April 1, 1999; 12(2): 210 - 223.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Castanos-Velez, S. Maerlan, L. M. Osorio, F. Aberg, P. Biberfeld, A. Orn, and M. E. Rottenberg
Trypanosoma cruzi Infection in Tumor Necrosis Factor Receptor p55-Deficient Mice
Infect. Immun., June 1, 1998; 66(6): 2960 - 2968.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.